US Stock MarketDetailed Quotes

GALT Galectin Therapeutics

Watchlist
  • 2.835
  • +0.065+2.35%
Close Nov 27 16:00 ET
  • 2.920
  • +0.085+3.00%
Post 20:01 ET
177.93MMarket Cap-3883P/E (TTM)

Galectin Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Galectin Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Galectin Therapeutics Earnings Reports

  • Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2024 and Provides Business Update

    Nov 14 08:01 ET

  • Galectin Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 14 07:56 ET

  • Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2024 and Provides Business Update

    Aug 13 07:57 ET

  • Galectin Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 13 07:52 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 20, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data